This directory provides summary information on the investors selected by Innovate UK as our pool of investor partners. For each investor partners it provides information on their main area of interest and how you should make contact. Each investor partner has demonstrated that they have the credibility, capability, capacity and appetite to invest in innovative, technology-led businesses that align with our investor partnership programmes.
Sainsbury’s Innovation Investments (Williams Technology Ventures Limited)
Sainsbury’s has committed to investing £1 billion towards becoming a net zero business by 2035.
Ascension Ventures Limited
Ascension is an early-stage venture capital firm built and managed by exited operators and entrepreneurs to back the next generation of tech and impact founders.
Minerva Business Angels (University of Warwick)
Minerva Business Angels is a brand name of the University of Warwick Science Park Ltd [“UWSP”], a wholly owned subsidiary of the University of Warwick.
Amadeus Capital Partners
Amadeus was founded in 1997 by Anne Glover (formerly at APAX Partners and Bain & Co) and Hermann Hauser (co-founder of Acorn Computers which spun out ARM, the microprocessor giant).
SFC Capital Ltd
SFC Capital is the UK pre-seed specialist and the most active venture fund in the UK.
Praetura Ventures Limited
Praetura Ventures is a Manchester-headquartered VC that backs exceptional early-stage businesses and founders across tech and life sciences with More Than Money.
Science Creates Ventures LLP
Science Creates Ventures (SCV) is a Bristol-based venture capital firm offering investment into early-stage UK deep tech companies, focusing on technologies that have the potential to improve healthcare, quality of life, and the environment around us.
Northern Gritstone Limited
Northern Gritstone is an independent business that helps amazing people who are living and working in the North of England to create the world-class businesses of tomorrow based on the world-class science and innovation that exists in the North of England today.
Oxford Science Enterprises Plc
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via its unique partnership with the University of Oxford, the world’s #1 research university.
Cancer Research Horizons
Cancer Research Horizons (CRH, trading name for Cancer Research Technology Limited) is a specialist drug discovery, development and commercialisation company wholly owned by Cancer Research UK (CRUK, the world’s leading cancer charity) that fast tracks scientific breakthroughs for patient benefit.
Development Bank of Wales
The Development Bank of Wales is committed to driving innovation and growth.
Octopus Ventures Limited
Octopus Ventures is one of the largest and most active venture capital investors in the UK and Europe, investing in and supporting the people, ideas and industries that are changing the world.
MMC Ventures Limited
MMC Ventures is one of the most active early-stage tech investors in Europe, focused on Series A.
East Innovate Ltd
East Innovate is a London based venture capital firm that invests in early-stage businesses developing advanced technologies in resource and energy systems.
Clarendon Fund Managers Limited
Clarendon Fund Managers manage Co-Fund NI, a £50m fund making equity investments in the Northern Ireland region.
Epidarex Capital is a venture capital firm led by a diverse team of early-stage investors building breakthrough life science companies in emerging hubs within the UK and US.
With more than $1.6 billion in assets under management and more than 300 investments per year, including 100+ pre-seed rounds in new startups, SOSV is one of the most active venture investors in the world.
Par Equity LLP
Par Equity is an active, hands-on investor, capable of taking the lead position on Seed to Series A investment rounds.
Sustainable Venture Development Partners
Sustainable Ventures is one of the UK’s leading specialist climate tech investors, having made 36 investments to date.
M Ventures is a strategic, corporate venture capital fund, with a mandate to invest in innovative technologies and products with the potential to significantly impact the business priorities of Merck.
Anglo American Decarbonisation Ventures
Anglo American’s Decarbonisation Ventures team invests in start-ups with the potential to achieve greater than 0.5Gt of decarbonisation per year of scale.